Decision Diagnostics Corp.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Keith Berman
- Full Time Employees
- 6
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 2660 Townsgate Road Westlake Village CA United States of America 91361
- IPO Date
- Feb 8, 2002
- CIK
- 0001144225
- Website
- decisiondiagnostics.co
- Similar Companies
- Business
- Decision Diagnostics Corp. Decision Diagnostics Corp. (DECN) manufactures and distributes non-prescription diagnostics and home testing products, with a focus on blood glucose test strips compatible with legacy meters; the company offers GenUltimate! glucose test strips as a replacement for LifeScan OneTouch Ultra; GenChoice! as a replacement for Abbott Freestyle Lite; GenPrecis! as a replacement for Lifescan OneTouch Select Plus; and GenUltimate! TBG as a replacement for LifeScan OneTouch Select, alongside PetSure! glucose test strips for dogs and cats compatible with Zoetis AlphaTrak and AlphaTrak II glucometers and the proprietary GenUltimate! 4Pets Glucose system including test strips and Avantage meter for testing dogs, cats, and horses. It also provides fulfillment services for direct-to-patient diabetes programs; smartphone-based electronic medical record technologies including MD@Hand for inpatient/outpatient management, Practice Probe for data mining from physician practice systems, and ResidenceWare for residential management information relay; and engages in the acquisition and holding of intellectual property such as patents, trademarks, and specialty manufacturing equipment. Founded in 2000 and headquartered in Westlake Village, California, the company operates through its subsidiary PharmaTech Solutions, Inc., which develops FDA and CE compliant testing solutions, and distributes products globally across the European Union, Russian Federation, post-Brexit UK, India, Malaysia, Indonesia, Singapore, Vietnam, Thailand, Mexico, Central and South America, Pakistan, South Africa, and the Middle East, with ongoing discussions for Canada and other regions. Previously known as InstaCare Corp., it changed its name to Decision Diagnostics Corp. in November 2011, marking a key rebranding to emphasize its diagnostics focus, while recent efforts center on expanding international distribution of its GenUltimate! branded strips and hiring sales personnel to support growth in emerging markets.
Financial Review: 10x Genomics (NASDAQ:TXG) & Decision Diagnostics (OTCMKTS:DECN)
Decision Diagnostics (OTCMKTS:DECN) vs. Privia Health Group (NASDAQ:PRVA) Critical Contrast
Head-To-Head Analysis: Decision Diagnostics (OTCMKTS:DECN) vs. Strata Skin Sciences (NASDAQ:SSKN)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
DECN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Decision Diagnostics Corp. Investors of Class Action and Encourages Shareholders to Contact the Firm
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm
Decision Diagnostics Shareholder Alert
DECISION DIAGNOSTICS CORP. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Decision Diagnostics Corp.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
Decision Diagnostics Shareholder Alert
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Decision Diagnostics Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 16, 2021 - DECN
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
Decision Diagnostics Update
Decision Diagnostics Class Action Reminder
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
Decision Diagnostics Shareholder Alert
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Decision Diagnostics Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 16, 2021 - DECN
DECISION DIAGNOSTICS UPDATE